BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Deals

  Golden Meditech Acquires 16.14% Interest of Ying Peng Hui Kang Fund

  Such investment in Ying Peng Hui Kang Fund may yield potential annual rate of return of 9%.

  February 4, 2018

   · 

  3 min read
• Drug Development

  Tetra Bio-Pharma Receives Health Canada Phase III Clinical Trial Approval For Smokable Dried Cannabis Prescription Drug

  Tetra Bio-Pharma announce that it has received a No Objection Letter (NOL) from the Therapeutic Products Directorate (TPD) Health Canada to its Clinical trial application (CTA) for the Company’s PPP001 prescription smokable dried cannabis product.

  February 4, 2018

   · 

  8 min read
• Business

  GC Pharma Reports Full Year 2017 Results

  GC Pharma (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the year ended 31 December 2017.

  February 4, 2018

   · 

  2 min read